Nanoengineering of gold nanoribbon-embedded isogenic stem cell-derived cardiac organoids.
Alejandra Patino-GuerreroHamid EsmaeiliRaymond Q MigrinoMehdi NikkhahPublished in: RSC advances (2023)
Cardiac tissue engineering is an emerging field providing tools to treat and study cardiovascular diseases (CVDs). In the past years, the integration of stem cell technologies with micro- and nanoengineering techniques has enabled the creation of novel engineered cardiac tissues (ECTs) with potential applications in disease modeling, drug screening, and regenerative medicine. However, a major unaddressed limitation of stem cell-derived ECTs is their immature state, resembling a neonatal phenotype and genotype. The modulation of the cellular microenvironment within the ECTs has been proposed as an efficient mechanism to promote cellular maturation and improve features such as cellular coupling and synchronization. The integration of biological and nanoscale cues in the ECTs could serve as a tool for the modification and control of the engineered tissue microenvironment. Here we present a proof-of-concept study for the integration of biofunctionalized gold nanoribbons (AuNRs) with hiPSC-derived isogenic cardiac organoids to enhance tissue function and maturation. We first present extensive characterization of the synthesized AuNRs, their PEGylation and cytotoxicity evaluation. We then evaluated the functional contractility and transcriptomic profile of cardiac organoids fabricated with hiPSC-derived cardiomyocytes (mono-culture) as well as with hiPSC-derived cardiomyocytes and cardiac fibroblasts (co-culture). We demonstrated that PEGylated AuNRs are biocompatible and do not induce cell death in hiPSC-derived cardiac cells and organoids. We also found an improved transcriptomic profile of the co-cultured organoids indicating maturation of the hiPSC-derived cardiomyocytes in the presence of cardiac fibroblasts. Overall, we present for the first time the integration of AuNRs into cardiac organoids, showing promising results for improved tissue function.
Keyphrases
- left ventricular
- stem cells
- cell death
- cardiovascular disease
- type diabetes
- heart failure
- metabolic syndrome
- tissue engineering
- drug delivery
- high resolution
- gene expression
- cell proliferation
- mass spectrometry
- coronary artery disease
- endothelial cells
- risk assessment
- cardiovascular risk factors
- drug release
- bone marrow
- atrial fibrillation
- extracellular matrix
- induced apoptosis
- smooth muscle